N/A N=79 Supportive Care

Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings

Addiction

Bottom Line

View on ClinicalTrials.gov: NCT02893514 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

May 2022

Primary outcome: Primary: Receipt of Brief Intervention (BI) for Drug Use at Baseline Visit — 17; 33 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Screening Only (SO) condition (Other); SUSIT Condition (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: NYU Langone Health
Primary completion: Mar 2019

Outcome Measures

Outcome	Result	p-value
PRIMARY Receipt of Brief Intervention (BI) for Drug Use at Baseline Visit	17; 33	—

Summary

This study will develop a clinical decision support tool that assists primary care providers in carrying out substance use interventions, and then compare (in Phase 2) two clinical scenarios, screening only (SO) vs. SUSIT, (on dose of substance use brief intervention received) and changes in drug use at 3 and 6 months, among primary care patients. Investigators will develop the Clinical Decision Support (CDS) component and then test the full SUSIT approach, using mixed methods to assess its acceptability and adoption, and gathering preliminary data on its efficacy for reducing unhealthy drug use. CDS development is concurrent with the SO phase to avoid losing valuable time, but will be conducted at a secondary study site to avoid contaminating the SO condition.

Eligibility Criteria

Inclusion Criteria

Substance use screening results (collected using the tablet-based screening tool) indicating current moderate risk drug use, based on a substance specific involvement score (SSIS) indicating current (past 3 months) use of at least one drug with a moderate risk level (SSIS 4-26), in the absence of any high-risk drug or alcohol use (SSIS 27+);
Presenting for visit with a participating PCP

Exclusion Criteria

Prior participation in the study (i.e. participation in the SO study phase would preclude participation in the SUSIT phase);
Attending a formal addiction treatment program (not including informal treatment such as Alcoholics Anonymous, Narcotics Anonymous), in the past 3 months;
Pregnant (based on self-report).

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02893514). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.